Updated:
Endologix
The Pounce Thrombectomy System now belongs to the Endologix Vascular Portfolio. The DETOUR System appears in the same listing. Endologix received a Medical...
Endologix
The Pounce Thrombectomy System now belongs to the Endologix Vascular Portfolio. The DETOUR System appears in the same listing. Endologix received a Medical Device Engineering Breakthrough award.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Santa Rosa
Corporate office
Santa Rosa, CA, United States
Sector focus
Frequently asked questions
What vascular conditions does Endologix target?
Endologix focuses on abdominal aortic aneurysms (AAA) and peripheral artery blockages, using the DETOUR System for EVAR and the Pounce Thrombectomy System for clot removal (per the firm's website, 2025).
How does Endologix differentiate itself from larger medical device companies?
Endologix pursues a focused pipeline targeting unmet clinical needs rather than offering a broad product range. It is the first to integrate immersive VR training for physicians, a feature it markets as a training innovation (per the firm's website, 2025).
What is the DETOUR System?
The DETOUR System is Endologix's novel approach to endovascular aneurysm repair, which earned a Medical Device Engineering Breakthrough award. It is designed to address limitations of standard EVAR procedures (per the firm's website, 2025).
Does Endologix disclose its financials or ownership?
No. Endologix does not publicly disclose AUM, revenue, or ownership structure. The firm appears as a private entity, and no funding rounds or investor information are available.
Where are Endologix's operations based?
The main office is in Santa Rosa, California. The firm also lists support offices in Italy, Poland, Germany, the UK, and Belgium (per the firm's website, 2025).
How does Endologix use virtual reality?
Endologix developed a VR-based procedural training program for its EVAR systems, allowing physicians to practice in a simulated environment. It describes this as a first in the EVAR space (per the firm's website, 2025).
What is the Pounce Thrombectomy System?
The Pounce device is a thrombectomy system for removing peripheral arterial clots, now part of Endologix's portfolio. It expands Endologix's focus beyond aneurysm repair into acute limb ischemia (per the firm's website, 2025).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: